News
-
Survey on THCS Transferability and Implementation Framework
The THCS Transferability and Implementation Framework aims to support, promote and accelerate the transfer and implementation of evidence-based solutions and practices in health and care systems. THCS is using this survey to gather comments and feedback on the framework for its further development.
-
WHO Guidance on Clinical Trials
The World Health Organization (WHO) released guidance to improve the design, conduct and oversight of clinical trials in countries of all income levels.
-
EP PerMed Symposium on Ethical Legal and Social Aspects of Personalised Medicine
EP PerMed organised a symposium on the ELSA of personalised medicine on 26 September 2024 in Brussels, Belgium. The event took place in a hybrid format with around 120 participants on site and online.
EP PerMed JTC 2024
#PMTargets
With its first joint transnational call, EP PerMed aims to fund research that fosters the identification or validation of targets for personalised medicine (PM) approaches. The deadline for submission of full proposals is now closed. It is expected that funding decisions will be communicated in October 2024.
Mission & Objectives
The vision of the European Partnership for Personalised Medicine is to improve health outcomes within sustainable healthcare systems through research, development, innovation and implementation of personalised medicine approaches for the benefit of patients, citizens, and society.
Dr. Wolfgang Ballensiefen, Coordinator
Governance & Boards
The European Partnership for Personalised Medicine gathers together more than 50 partners from over 20 countries. The Consortium is managed by a so-called Coordination Unit (CU) and General Assembly (GeA). The day-to-day business, planning and implementation of activities is realized through five Work Packages. The EP PerMed overarching Advisory Bodies are ICPerMed, an Advisory Board and a Stakeholder Forum.